Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 7/2023

28.04.2023 | Acute Pain Medicine (R Urman, Section Editor)

Treatment of Acute Pain in Patients on Naltrexone: A Narrative Review

verfasst von: Amber N. Edinoff, Chelsi J. Flanagan, Evan S. Sinnathamby, Nathan Z. Pearl, Eric D. Jackson, Danielle M. Wenger, Elyse M. Cornett, Adam M. Kaye, Alan D. Kaye

Erschienen in: Current Pain and Headache Reports | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The tissue damage and trauma associated with surgery almost always result in acute postoperative pain. The intensity of postoperative pain can range from mild to severe. Naltrexone is suitable for patients who do not wish to be on an agonist treatment such as methadone or buprenorphine. However, naltrexone has been shown to complicate postoperative pain management.

Recent Findings

Multiple studies have found that the use of naltrexone can increase the opioid requirement for postoperative pain control. Other modalities exist that can help outside of opioids such as ketamine, lidocaine/bupivacaine, duloxetine, and non-pharmacological management can help manage pain. Multimodal pain regiments should also be employed in patients.

Summary

In addition to traditional methods for postoperative pain management, other methods of acute pain control exist that can help mitigate opioid dependence and help control pain in patients who use naltrexone for their substance use disorders.
Literatur
1.
Loeser JD, Melzack R. Pain: an overview. Lancet. 1999.
2.
Moore AR, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. “Evidence” in chronic pain – establishing best practice in the reporting of systematic reviews. Pain. 2010;150(3):386–9.PubMedCrossRef
3.
McCarberg B, Gibofsky A. Need to develop new nonsteroidal anti-inflammatory drug formulations. Clin Ther. 2012;34(9):1954–63.PubMedCrossRef
4.
Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013;87(11):766–72.PubMed
5.
Nafziger AN, Barkin RL. Opioid therapy in acute and chronic pain. J Clin Pharmacol. 2018;58(9):1111–22.PubMedCrossRef
6.
Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007;102(11):2459–63.PubMedCrossRef
7.
The American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting. Anesthesiology. 2012;116(2):248–73.CrossRef
8.
9.
10.
11.
Sinatra R. Causes and consequences of inadequate management of acute pain. Pain Med. 2010;11(12):1859–71.PubMedCrossRef
12.
13.
Meyer RA. Peripheral mechanisms of cutaneous nociception. Wall Melzacks Textb Pain. 2006.
14.
Hutchison RW. Challenges in acute post-operative pain management. Am J Health Syst Pharm. 2007;64(6_Supplement_4):S2–5.PubMedCrossRef
15.
Small C, Laycock H. Acute postoperative pain management. J Br Surg. 2020;107(2):e70-80.CrossRef
16.
17.
Wu CL, Raja SN. Treatment of acute postoperative pain. The lancet. 2011;377(9784):2215–25.CrossRef
18.
Aboujaoude E, Salame WO. Naltrexone: a pan-addiction treatment? CNS Drugs. 2016;30(8):719–33.PubMedCrossRef
19.
20.
Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101:142–51.PubMedCrossRef
21.
Petry NM. Should the scope of addictive behaviors be broadened to include pathological gambling? Addiction. 2006;101:152–60.PubMedCrossRef
22.
Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32(4):777–810.PubMedCrossRef
23.
Olmstead MC, Ouagazzal AM, Kieffer BL. Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. Hashimoto K, editor. PLoS ONE. 2009;4(2):e4410.PubMedPubMedCentralCrossRef
24.
Kim SW, Grant JE, Adson DE, Remmel RP. A preliminary report on possible naltrexone and nonsteroidal analgesic interactions. J Clin Psychopharmacol. 2001;21(6):632–4.PubMedCrossRef
25.
Yoburn BC, Luke MC, Pasternak GW, Inturrisi CE. Upregulation of opioid receptor subtypes correlates with potency changes of morphine and dadle. Life Sci. 1988;43(16):1319–24.PubMedCrossRef
26.
Vickers JA. Naltrexone and problems in pain management. BMJ. 2006;332.
27.
Br JP. Naltrexone: a review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs. 1988;35:192–213.CrossRef
28.
29.
Singh D, Saadabadi A. Naltrexone. 2018.
30.
31.
Lobmaier PP, Kunøe N, Gossop M, Waal H. Naltrexone depot formulations for opioid and alcohol dependence: a systematic review. CNS Neurosci Ther. 2011;17(6):629–36.PubMedCrossRef
32.
Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev. 2003;(2).
33.
34.
Mason BJ, Heyser CJ. Alcohol use disorder: the role of medication in recovery. Alcohol Res Curr Rev. 2021;41(1).
35.
Santos GM, Ikeda J, Coffin P, Walker J, Matheson T, Ali A, et al. Targeted oral naltrexone for mild to moderate alcohol use disorder among sexual and gender minority men: a randomized trial. Am J Psychiatry. 2022;179(12):915–26.PubMedPubMedCentralCrossRef
36.
Ciraulo AROS. DAcombine Study Research Group Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2003;2006(29517):2017.
37.
Pettinati HM, Volpicelli JR, Pierce JD Jr, O’brien CP. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis. 2000;19(1):71–83.PubMedCrossRef
38.
39.
Kim PS, Fishman MA. Low-dose naltrexone for chronic pain: update and systemic review. Curr Pain Headache Rep. 2020;24:1–8.CrossRef
40.
Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn’s disease, and other chronic pain disorders. Pharmacother J Hum Pharmacol Drug Ther. 2018;38(3):382–9.CrossRef
41.
Jagla C, Martus P, Stein C. Peripheral opioid receptor blockade increases postoperative morphine demands—a randomized, double-blind, placebo-controlled trial. Pain. 2014;155(10):2056–62.PubMedCrossRef
42.
Brown DR, Goldberg LI. The use of quaternary narcotic antagonists in opiate research. Neuropharmacology. 1985;24(3):181–91.PubMedCrossRef
43.
Russell J, Bass P, Goldberg LI, Schuster CR, Merz H. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists. Eur J Pharmacol. 1982;78(3):255–61.PubMedCrossRef
44.
Wiftels B, Glosten B, Faure EAM, Moawad AH, Ismail M, Hibbard J, et al. Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes. Anesth Analg. 1993.
45.
Lesscher HMB, Bailey A, Burbach JPH, Van Ree JM, Kitchen I, Gerrits MAFM. Receptor-selective changes in μ-, δ- and κ-opioid receptors after chronic naltrexone treatment in mice: Opioid receptor regulation by chronic naltrexone. Eur J Neurosci. 2003;17(5):1006–12.PubMedCrossRef
46.
Dı́az A, Pazos A, Flórez J, Ayesta FJ, Santana V, Hurlé MA. Regulation of μ-opioid receptors, G-protein-coupled receptor kinases and β-arrestin 2 in the rat brain after chronic opioid receptor antagonism. Neuroscience. 2002;112(2):345–53.
47.
Tempel A, Gardner EL, Zukin RS. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation. J Pharmacol Exp Ther. 1985;232(2):439–44.PubMed
48.
Curatolo C, Trinh M. Challenges in the perioperative management of the patient receiving extended-release naltrexone. Case Rep. 2014;3(11):142–4.
49.
Dean RL, Todtenkopf MS, Deaver DR, Arastu MF, Dong N, Reitano K, et al. Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone. Pharmacol Biochem Behav. 2008;89(4):515–22.PubMedCrossRef
50.
Kapila A, Glass PSA, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995;83(5):968–75.PubMedCrossRef
51.
Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825–73.PubMedCrossRef
52.
Wampole CR, Smith KE. Beyond opioids for pain management in adult critically ill patients. J Pharm Pract. 2019;32(3):256–70.PubMedCrossRef
53.
Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg. 1998;87(5):1186.PubMed
54.
Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 1991;14(2):60–7.PubMedCrossRef
55.
Hustveit O, Maurset A, Oye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol. 1995;77(6):355–9.PubMedCrossRef
56.
Smith DJ, Bouchal RL, deSanctis CA, Monroe PJ, Amedro JB, Perrotti JM, et al. Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology. 1987;26(9):1253–60.PubMedCrossRef
57.
Wagner LE, Gingrich KJ, Kulli JC, Yang J. Ketamine blockade of voltage-gated sodium channels: evidence for a shared receptor site with local anesthetics. Anesthesiology. 2001;95(6):1406–13.PubMedCrossRef
58.
Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013;19(6):370–80.PubMedPubMedCentralCrossRef
59.
Schwenk ES, Viscusi ER, Buvanendran A, Hurley RW, Wasan AD, Narouze S, et al. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):456–66.PubMedPubMedCentral
60.
61.
Gharaei B, Jafari A, Aghamohammadi H, Kamranmanesh M, Poorzamani M, Elyassi H, et al. Opioid-sparing effect of preemptive bolus low-dose ketamine for moderate sedation in opioid abusers undergoing extracorporeal shock wave lithotripsy: a randomized clinical trial. Anesth Analg. 2013;116(1):75–80.PubMedCrossRef
62.
63.
Toleska M, Dimitrovski A, Shosholcheva M, Kartalov A, Kuzmanovska B, Dimitrovska NT. Pain and multimodal analgesia in laparoscopic cholecystectomy. Pril Makedon Akad Na Nauk Umet Oddelenie Za Med Nauki. 2022;43(2):41–9.
64.
Liam BL, Yim CF, Chong JL. Dose response study of lidocaine 1% for spinal anaesthesia for lower limb and perineal surgery. Can J Anaesth J Can Anesth. 1998;45(7):645–50.CrossRef
65.
Schneider M, Ettlin T, Kaufmann M, Schumacher P, Urwyler A, Hampl K, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg. 1993;76(5):1154–7.PubMedCrossRef
66.
Hampl KF, Heinzmann-Wiedmer S, Luginbuehl I, Harms C, Seeberger M, Schneider MC, et al. Transient neurologic symptoms after spinal anesthesia: a lower incidence with prilocaine and bupivacaine than with lidocaine. Anesthesiology. 1998;88(3):629–33.PubMedCrossRef
67.
68.
Sahmeddini MA, Khosravi MB, Farbood A. Comparison of perioperative systemic lidocaine or systemic ketamine in acute pain management of patients with opioid use disorder after orthopedic surgery. J Addict Med. 2019;13(3):220–6.PubMedCrossRef
69.
Malik O, Kaye AD, Kaye A, Belani K, Urman RD. Emerging roles of liposomal bupivacaine in anesthesia practice. J Anaesthesiol Clin Pharmacol. 2017;33(2):151–6.PubMedPubMedCentralCrossRef
70.
Tran AT, Rizk E, Haas EM, Naufal G, Zhong L, Swan JT. Real-world data on liposomal bupivacaine and inpatient hospital costs after colorectal surgery. J Surg Res. 2022;272:175–83.PubMedCrossRef
71.
Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty. 2018;33(1):90–6.PubMedCrossRef
72.
Iyengar S, Webster AA, Hemrick-Luecke SK, Xu JY, Simmons RMA. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther. 2004;311(2):576–84.PubMedCrossRef
73.
YaDeau JT, Mayman DJ, Jules-Elysee KM, Lin Y, Padgett DE, DeMeo DA, et al. Effect of duloxetine on opioid use and pain after total knee arthroplasty: a triple-blinded randomized controlled trial. J Arthroplasty. 2022;37(6S):S147–54.PubMedCrossRef
74.
Zorrilla-Vaca A, Stone A, Caballero-Lozada AF, Paredes S, Grant MC. Perioperative duloxetine for acute postoperative analgesia: a meta-analysis of randomized trials. Reg Anesth Pain Med. 2019;rapm-2019-100687.
75.
Cheifetz O, Lucy SD, Overend TJ, Crowe J. The effect of abdominal support on functional outcomes in patients following major abdominal surgery: a randomized controlled trial. Physiother Can Physiother Can. 2010;62(3):242–53.PubMedCrossRef
76.
Hoskins C, Dempsey A, Brou L. A mixed-methods study of the effect of abdominal binders on opioid use and postoperative pain after cesarean birth. Nurs Womens Health. 2022;26(1):30–7.PubMedCrossRef
77.
Armaghani SJ, Lee DS, Bible JE, Archer KR, Shau DN, Kay H, et al. Preoperative opioid use and its association with perioperative opioid demand and postoperative opioid independence in patients undergoing spine surgery. Spine. 2014;39(25):E1524-1530.PubMedCrossRef
78.
Uhrbrand P, Rasmussen MM, Haroutounian S, Nikolajsen L. Shared decision-making approach to taper postoperative opioids in spine surgery patients with preoperative opioid use: a randomized controlled trial. Pain. 2022;163(5):e634–41.PubMedCrossRef
Metadaten
Titel
Treatment of Acute Pain in Patients on Naltrexone: A Narrative Review
verfasst von
Amber N. Edinoff
Chelsi J. Flanagan
Evan S. Sinnathamby
Nathan Z. Pearl
Eric D. Jackson
Danielle M. Wenger
Elyse M. Cornett
Adam M. Kaye
Alan D. Kaye
Publikationsdatum
28.04.2023
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 7/2023
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-023-01110-9

Neu im Fachgebiet AINS

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Blutdrucksenkung schon im Rettungswagen bei akutem Schlaganfall?

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise